News

Deal Announcements

Sigma-Aldrich Acquires Molecular Medicine BioServices

Wednesday, May 9, 2007 5:00:00 AM PDT | VentureDeal Staff
ST. LOUIS, MO -- Biotech supplier Sigma-Aldrich Corporation (Nasdaq: SIAL)  announced the acquisition of Molecular Medicine BioServices (MMB).  Financial terms of the transaction were not disclosed.

MMB is a biopharmaceutical contract manufacturing organization with a core expertise in the development and clinical manufacturing of viral products for pharmaceutical companies to test treatments and vaccines.

According to Sigma-Aldrich president Frank Wicks, the company acquired MMB to continue their "push into niche biologics, giving us the critical capability to manufacture virus."

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1